We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$2B
AUM Growth
+$231M
Cap. Flow
+$286M
Cap. Flow %
14.32%
Top 10 Hldgs %
8.34%
Holding
1,933
New
619
Increased
448
Reduced
311
Closed
543

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$17.8M
2
INTC icon
Intel
INTC
+$17.4M
3
EOG icon
EOG Resources
EOG
+$12.8M
4
AMZN icon
Amazon
AMZN
+$11.9M
5
NVDA icon
NVIDIA
NVDA
+$10.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$25M
2
HLF icon
Herbalife
HLF
+$20.8M
3
HD icon
Home Depot
HD
+$12.7M
4
BKNG icon
Booking.com
BKNG
+$12M
5
CMG icon
Chipotle Mexican Grill
CMG
+$11.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.88%
2 Technology 15.21%
3 Financials 12.06%
4 Industrials 12.01%
5 Healthcare 11.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRDN icon
1376
Viridian Therapeutics
VRDN
$2.2B
$16K ﹤0.01%
1,430
+516
+56% +$11.4K
MBII
1377
DELISTED
Marrone Bio Innovations, Inc.
MBII
$16K ﹤0.01%
11,529
-7,300
-39% -$10.3K
COGT icon
1378
Cogent Biosciences
COGT
$6.76B
$15K ﹤0.01%
+2,588
New +$21K
USAU icon
1379
US Gold Corp
USAU
$213M
$15K ﹤0.01%
+1,594
New +$16.1K
HTGM
1380
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$15K ﹤0.01%
123
+64
+108% +$12.9K
LPTH icon
1381
Lightpath Technologies
LPTH
$590M
$13K ﹤0.01%
+15,122
New +$12.1K
LCTX icon
1382
Lineage Cell Therapeutics
LCTX
$264M
$12K ﹤0.01%
12,631
-17,100
-58% -$17.7K
TENX icon
1383
Tenax Therapeutics
TENX
$393M
$12K ﹤0.01%
+6
New +$12.5K
ASXC
1384
DELISTED
Asensus Surgical, Inc.
ASXC
$10K ﹤0.01%
1,253
-4,853
-79% -$66K
AIM
1385
AIM ImmunoTech
AIM
$6.65M
$9K ﹤0.01%
124
+24
+24% +$5.81K
NAVB
1386
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$7K ﹤0.01%
+10,276
New +$6.32K
AA icon
1387
Alcoa
AA
$11.3B
-189,904
Closed -$4.45M
AAL icon
1388
American Airlines Group
AAL
$9.82B
-36,540
Closed -$1.19M
AAP icon
1389
Advance Auto Parts
AAP
$3.53B
-60,300
Closed -$9.29M
AAPL icon
1390
Apple
AAPL
$4.97T
-504,936
Closed -$25M
ABEO icon
1391
Abeona Therapeutics
ABEO
$355M
-684
Closed -$82K
ACCO icon
1392
Acco Brands
ACCO
$399M
-89,090
Closed -$701K
ACGL icon
1393
Arch Capital
ACGL
$36.5B
-9,600
Closed -$356K
ACIU icon
1394
AC Immune
ACIU
$231M
-30,985
Closed -$172K
ACM icon
1395
Aecom
ACM
$9.46B
-40,902
Closed -$1.55M
ADEA icon
1396
Adeia
ADEA
$2.55B
-145,643
Closed -$793K
ADMA icon
1397
ADMA Biologics
ADMA
$2.02B
-70,665
Closed -$273K
ADP icon
1398
Automatic Data Processing
ADP
$109B
-21,799
Closed -$3.6M
ADUS icon
1399
Addus HomeCare
ADUS
$2.22B
-7,159
Closed -$537K
AEG icon
1400
Aegon
AEG
$13.3B
-28,607
Closed -$126K

Similar funds

A.R.T. Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, A.R.T. Advisors held 1,933 positions worth $2B, up 13% from $1.77B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

A.R.T. Advisors deployed $286M of net new capital in Q3 2019, opening 619 new positions and adding to 448 existing holdings. Its largest new stake was Netflix: 570,000 shares worth $15.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, down from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Booking.com, an estimated $12M trimmed.

  • A.R.T. Advisors's largest Q3 2019 buy was Netflix: 570,000 shares worth $15.3M.
  • A.R.T. Advisors added most to Intel in Q3 2019, an estimated $17.4M increase.
  • A.R.T. Advisors's biggest Q3 2019 reduction was Booking.com, cutting an estimated $12M.
  • A.R.T. Advisors fully exited Apple in Q3 2019, selling an estimated $25M.
  • A.R.T. Advisors's ten largest holdings make up 8.3% of its $2B portfolio in Q3 2019.
  • A.R.T. Advisors opened 619 new positions and closed 543 in Q3 2019.
  • A.R.T. Advisors's portfolio value rose 13% quarter-over-quarter to $2B.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.